Oragenics, Inc. (OGEN) vs Trevena, Inc. (TRVN)
- Oragenics, Inc. OGEN 0.43 −2.27%
- Trevena, Inc. TRVN 0.00 −100.00%
Oragenics, Inc. and Trevena, Inc. are both Biotechnology companies. Oragenics, Inc. and Trevena, Inc. are of similar size ($2.0M and $1.8M). Trevena, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Oragenics, Inc. grew revenue faster over the last twelve months: −75.1% against −83.0%. Oragenics, Inc. has the higher net margin (0.00% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Oragenics, Inc. leads on 9 and Trevena, Inc. on 6.
Valuation
Profitability
| Metric | OGEN | TRVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.89% | (190.29%) | 65.16% |
| Operating margin | 0.00% | (5,879.85%) | 0.00% |
| Net margin | 0.00% | (6,233.70%) | 0.00% |
| Free cash flow margin | 0.00% | (4,961.72%) | 0.00% |
| Return on equity | (1,307.07%) | 344.49% | (56.36%) |
| Return on assets | (264.23%) | (105.83%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack